Literature DB >> 18295736

B cell autonomous TLR signaling and autoimmunity.

Almut Meyer-Bahlburg1, David J Rawlings.   

Abstract

B cells play a central role in the pathogenesis of multiple autoimmune diseases and the recognition of the importance of B cells in these disorders has grown dramatically in association with the remarkable success of B cell depletion as a treatment for autoimmunity. The precise mechanisms that promote alterations in B cell tolerance remain incompletely defined. There is increasing evidence, however, that TLRs play a major role in these events. Stimulation of B cells via the TLR pathway not only leads to an increase in antibody production but also promotes additional changes including cytokine production and up-regulation of activation markers increasing the effectiveness of B cells as APCs. Understanding the role of TLRs in systemic autoimmunity will not only provide insight into the disease pathogenesis but may also lead to the development of novel therapies. This article gives an overview of TLR signaling in B cells and the possible involvement of such signals in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295736      PMCID: PMC2763483          DOI: 10.1016/j.autrev.2007.11.027

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  20 in total

Review 1.  Autoreactivity by design: innate B and T lymphocytes.

Authors:  A Bendelac; M Bonneville; J F Kearney
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

2.  CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice.

Authors:  Woong-Jai Won; John F Kearney
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

3.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

4.  TLR9 signaling in B cells determines class switch recombination to IgG2a.

Authors:  Andrea Jegerlehner; Patrik Maurer; Juliana Bessa; Heather J Hinton; Manfred Kopf; Martin F Bachmann
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

5.  Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity.

Authors:  Kathryn E Gunn; Joseph W Brewer
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

Review 6.  Toll-like receptors and innate immunity.

Authors:  Satoshi Uematsu; Shizuo Akira
Journal:  J Mol Med (Berl)       Date:  2006-09       Impact factor: 4.599

Review 7.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

8.  Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication.

Authors:  Prapaporn Pisitkun; Jonathan A Deane; Michael J Difilippantonio; Tatyana Tarasenko; Anne B Satterthwaite; Silvia Bolland
Journal:  Science       Date:  2006-05-18       Impact factor: 47.728

9.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

Review 10.  Toll-like receptors in systemic autoimmune disease.

Authors:  Ann Marshak-Rothstein
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

View more
  31 in total

Review 1.  Regulation of B-cell responses by Toll-like receptors.

Authors:  Edward P Browne
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

2.  A contemporary update on scleroderma.

Authors:  Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 3.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 4.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

5.  Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.

Authors:  Eleni Arvaniti; Stavroula Ntoufa; Nikos Papakonstantinou; Tasoula Touloumenidou; Nikolaos Laoutaris; Achilles Anagnostopoulos; Klea Lamnissou; Federico Caligaris-Cappio; Kostas Stamatopoulos; Paolo Ghia; Marta Muzio; Chrysoula Belessi
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

Review 6.  Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

Authors:  Jing Li; Xiaohui Wang; Fengchun Zhang; Hang Yin
Journal:  Pharmacol Ther       Date:  2013-03-24       Impact factor: 12.310

7.  Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals.

Authors:  Almut Meyer-Bahlburg; Ashok D Bandaranayake; Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 8.  Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.

Authors:  Subhrajit Saha; Arlene Tieng; K Peter Pepeljugoski; Gisele Zandamn-Goddard; Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

9.  B7-1/2 (CD80/CD86) direct signaling to B cells enhances IgG secretion.

Authors:  Friederike C Rau; Jacquelyn Dieter; Zhang Luo; Stephen O Priest; Nicole Baumgarth
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 10.  Dysregulation of germinal centres in autoimmune disease.

Authors:  Carola G Vinuesa; Iñaki Sanz; Matthew C Cook
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.